Iran’s Health Ministry addresses the problem of amphetamine useFeb 23, 2016
While opium use has been identified as the main drug problem in Iran for centuries, since a decade ago the country has encountered an emerging trend of stimulant use.
The main stimulant of use in Iran is methamphetamine – a potent psychostimulant drug which its use is associated with increased risk of HIV transmission, psychosis and cardiovascular problem and stroke.
In line with this, piloting prevention programmes for amphetamine users has been included in the HIV/AIDS New Funding Model of the Global Fund. One of the activities under this initiative was the organization of training workshops, one of which is currently being held in Ahvaz from 23 to 25 February.
The workshop’s focus is on the harm reduction services for amphetamine users. This event is being held in cooperation with the University of Medical Sciences, Mental Health, Social Health, Addiction Office of Ministry of Health and Medical Education and with financial support of the Global Fund.
The workshop is attended by 70 participants – technical officers of universities and managers of Drop-In-Centres (DIC) – from 21 universities of medicals sciences namely: Shahid Beheshti, Tehran, Qazvin, Isfahan, Mashhad, Alborz, Ahvaz, Kerman, Kermanshah, Abadan, Behbahan, Dezfool, Sanandaj, Shiraz, Qom, Kohkiloye va Boyerahmad, Lorestan, Mazandaran, Hormozgan and Yazd.
Among the attendees at the opening ceremony were Dr. Noroozi, Head of Substance Abuse Prevention and Treatment Office of Ministry of Health, Dr. Eidani, Chancellor of Ahvaz University of Medical Sciences, Dr. Salmanzadeh, Health Deputy of Ahvaz University of Medical Sciences and Secretariat of Drug Control Coordination Council of Ahvaz Province.
The aim of the event is to train participants on different subjects such as requirements for establishing a DIC, requirements for outreach teams, needle and syringes programme, harm reduction programme, stimulant drugs, comprehensive service package for stimulant users, identification and management of emergency situation associated with stimulant users, HIV/AIDS counseling and testing, harm reduction education for stimulant users, prevention and intervention of overdose, stimulant drugs and sexual behavior, motivational brief intervention, harm reduction model for stimulant drugs as well as quarterly reporting forms and formats.
This initiative is carried out under the three party partnership of the Government of Islamic Republic of Iran represented by the Centre for Communicable Disease Control of Ministry of Health, the United Nations Development Programme (UNDP) and the Global Fund to Fight AIDS, Tuberculosis and Malaria.